J&J | JNJ - Sales Revenues


J&J reported $25.31B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
AbbVie USD 16.99B 1.99B Jun/2026
Abbott USD 12.59B 1.43B Jun/2026
Amgen USD 10.1B 1.48B Jun/2026
AstraZeneca USD 15.38B 90M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Biogen USD 2.74B 490M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
CONMED USD 343.5M 26.5M Jun/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Eli Lilly USD 22.97B 3.17B Jun/2026
Gilead Sciences USD 7.8B 800M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Medtronic USD 9.8B 0 Jun/2026
Merck USD 16.6B 310M Jun/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Novartis USD 14.41B 1.3B Jun/2026
Pfizer USD 15.03B 530M Jun/2026
Regeneron Pharmaceuticals USD 4.29B 690M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teva Pharmaceutical Industries USD 12.67B 900M Jun/2026
Vertex Pharmaceuticals USD 3.33B 340M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026
Zoetis USD 2.5B 200M Jun/2026